ProPhase Labs Inc
(NASDAQ: PRPH)
-0.01
-0.63%
| Exchange: | NASDAQ |
| Stock: | ProPhase Labs Inc |
| Industry: | Drug Related Products |
| Employees: | 49 |
| ProPhase Labs, Inc. is a manufacturer, marketer and distributor of a ranges of homeopathic and health products that are offered to the general public. The Company is also engaged in the research and development of potential over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. The Company's primary business is manufacturing, distribution, marketing and selling of OTC cold remedy products to consumers through food, multi-outlet pharmacy and chain drug stores, wholesalers and mass merchandisers. The Company's brand is Cold-EEZEO Cold Remedy and the Company's principal product is Cold-EEZEO zinc gluconate lozenges, used to reduce the duration and severity of symptoms of the common cold. In August 2011, the Company launched Cold-EEZE Oral Spray. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
